Intertek, which provides a wide range of testing services for OINDPs, has announced a new partnership with particle engineering specialist CrystecPharma for creation of a "fast to clinic" development platform for dry powder inhaler formulations. The company says that as of January 2025, the new platform will halve the time typically required to develop DPI … [Read more...] about Intertek and CrystecPharma partner on DPI development services
Products and Services
Bespak and OzUK extend their partnership on LGWP MDI development services
Expanding on a partnership established in 2023, and following the closure of Bespak's OINDP development facilities in North Carolina, CDMO Bespak and CRO OzUK say that they will now offer continuity of low global warming potential (LGWP) propellant development projects between the two companies, with projects started at OzUK facilities then transfering to Bespak for … [Read more...] about Bespak and OzUK extend their partnership on LGWP MDI development services
Orbia announces planned expansion of HFA 152a manufacturing capacity
Orbia Fluor & Energy Materials (formerly Koura Global) has announced plans for a new manufacturing facility for its Zephex HFA 152a LGWP MDI propellant, saying that the plant will produce significantly more 152a than the first plant that was opened in 2022. The announcement does not specify the size of the increase in capacity or the size of the investment. The … [Read more...] about Orbia announces planned expansion of HFA 152a manufacturing capacity
Hovione completes expansion of spray drying facilities in US and Ireland
CDMO Hovione has announced the completion of expansion projects at its facilities in East Windsor, NJ, USA and Ringaskiddy, Cork, Ireland that its says will provide a significant increase in the company's spray drying capacity and will create more than 40 jobs. In November 2021, Hovione said that it was launching a $170 million project to increase capacity at its US, … [Read more...] about Hovione completes expansion of spray drying facilities in US and Ireland
CHI partners with Aptar Pharma for commercialization of the Quattrii DPI platform
Aptar Pharma will commercialize and promote Cambridge Healthcare Innovations' Quattrii blister-based dry powder inhaler platform, the companies said. According to the announcement, the platform is tunable and can be used with carrier or API-only formulations. CHI's web site says that the Quattrii DPI can be filled with up to 150 mg of powder and is capable of … [Read more...] about CHI partners with Aptar Pharma for commercialization of the Quattrii DPI platform
Bespak announces closure of its North Carolina facilities
Inhalation CDMO Bespak recently announced that it will close its site in Research Triangle Park, NC, USA by the end of the first quarter of 2025. Bespak spun out from Recipharm earlier this year with the stated purpose of focusing on the transition of MDIs to LGWP propellants. According to the company's announcement, it will be moving "selected product … [Read more...] about Bespak announces closure of its North Carolina facilities
OzUK announces new GLP pilot plant for development of MDIs with LGWP propellants
CRO OzUK has announced the availability of a new GLP pilot plant designed for pilot and feasibility studies of both solution and suspension MDIs filled with low global warming potential (LGWP) propellants. OzUK announced plans for the new facility in December 2023. According to the company, the new facility meets ATEX (Atmosphères Explosibles) standards for safety, … [Read more...] about OzUK announces new GLP pilot plant for development of MDIs with LGWP propellants
Polyrizon raises $4.2 million for continued development of its intranasal hydrogels
Intranasal hydrogel maker Polyrizon announced that it has closed a $4.2 million IPO, with a possibility of the total rising to $4.82 million if Aegis Capital exercises an option to purchase additional shares. Polyrizon said that funds from the IPO will be used for development of its hydrogel products for nasal drug delivery, called Capture and Contain (C&C), a … [Read more...] about Polyrizon raises $4.2 million for continued development of its intranasal hydrogels
Honeywell announces agreement to supply HFO 1234ze for DevPro albuterol MDI, spin off of the advanced materials business
Honeywell announced that it has signed a long-term supply agreement with DevPro Biopharma related to the use of Honeywell's Solstice Air HFO-1234ze in DevPro's DP007 albuterol metered dose inhaler. Earlier this year, DevPro and CDMO Bespak announced that they were collaborating on development of the LGWP propellant MDI. Recipharm, which later spun out Bespak, and … [Read more...] about Honeywell announces agreement to supply HFO 1234ze for DevPro albuterol MDI, spin off of the advanced materials business
Aptar acquires SipNose nasal delivery technology
Aptar Pharma announced that it has acquired nasal delivery technology from Israeli nasal drug developer SipNose Nasal Delivery Systems. In addition to developing devices, SipNose has a pipeline of candidates developed in-house and candidates in development with partners, such as Noveome's ST266 secretome. According to Aptar, the company has acquired all of … [Read more...] about Aptar acquires SipNose nasal delivery technology